Identification of novel serum microRNAs in age-related macular degeneration

Elshelmani, Hanan and Wride, Michael A. and Saad, Tahira and Rani, Sweta and Kelly, David J. and Keegan, David (2020) Identification of novel serum microRNAs in age-related macular degeneration. Translational Vision Science and Technology, 9 (4). pp. 1-13. ISSN 2164-2591

Full text not available from this repository. (Request a copy)


Purpose: To identify circulating microRNAs (miRNA) associated with age-related macular degeneration (AMD). Thus differentially expressed serum miRNA could be used as AMD biomarkers. Methods: This study involved total RNA isolation from sera from patients with atrophic AMD (n = 10), neovascular AMD (n = 10), and age-and sex-matched controls (n = 10). A total of 377 miRNAs were coanalyzed using array technologies, and differentially regulated miRNAs were determined. Extensive validation studies (n = 90) of serum from AMD patients and controls confirmed initial results. Total RNA isolation was carried out from sera from patients with atrophic AMD (n = 30), neovascular AMD (n = 30), and controls (n = 30). Fourteen miRNAs from the discovery dataset were coanalyzed using quantitative real-time polymerase chain reaction (qRT-PCR) to validate their presence. Results: Unsupervised hierarchical clustering indicated that AMD serum specimens have a different miRNA profile to healthy controls. We successfully identified and validated the differentially regulated miRNAs in serum from AMD patients versus controls. The biomarker potential of three miRNAs (miR-126, miR-19a, and miR-410) was confirmed by qRT-PCR, with significantly increased quantities in serum of AMD patients compared with healthy controls. Conclusions: Increased quantities of miR-126, miR-410, and miR-19a in serum from AMD patients indicate that these miRNAs could potentially serve as diagnostic AMD biomarkers. All three miRNAs significantly correlated with AMD pathogenesis. Translational Relevance: The discovery of new AMD miRNA may act as biomarkers in evaluating AMD diagnosis and prognosis.

Item Type: Article
Additional Information: Funding Information: Supported by the Irish Research Council for Science, Engineering, and Technology/EMBARK Initiative, the Mater Vision Institute, the Libyan Ministry of Higher Education and Scientific Research, and Fighting Blindness Ireland (FB14 SAA). Publisher Copyright: © 2020 The Authors.
Uncontrolled Keywords: /dk/atira/pure/subjectarea/asjc/2200/2204
Departments or Groups:
Depositing User: Admin SSL
Date Deposited: 19 Oct 2022 23:01
Last Modified: 13 Aug 2023 02:05

Actions (login required)

View Item View Item